Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc (CNTA) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
cnta · stock forecast · 14 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 14 Wall Street analysts in the past 3 months
Buy
14 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$42.00
Consensus
$39.50
-0.4% upside
Low
$38.00
Median: $39 · Last Close: $39.65
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$39.50
-0.4% upside
High Target
$42
5.9%
Low Target
$38
-4.1%
Current Price
$39.65
as of today
Based on analyst price targets, the CNTA stock price prediction for the next 12 months ranges from $38 to $42. The consensus CNTA price forecast of $39.50 implies -0.4% upside from the current price of $39.65.
Short-Term Price Prediction
BullAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $39.68 | ↑ 0.09% |
1-day model range: $39.67–$39.69. Peak: $39.69 (+0.09%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $67 | +68.1% |
| 2028 | $94 | +136.7% |
| 2029 | $117 | +194.7% |
| 2030 | $134 | +238.1% |
| 2031 | — | +267.9% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CNTA · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-20 | Wells Fargo | Downgrade ↓ | Overweight→Equal Weight |
| 2026-04-02 | Guggenheim | Downgrade ↓ | Buy→Neutral |
| 2026-04-01 | Leerink Partners | Downgrade ↓ | Outperform→Market Perform |
| 2026-03-31 | Needham | Downgrade ↓ | Buy→Hold |
| 2026-03-31 | Wolfe Research | Downgrade ↓ | Outperform→Peer Perform |
| 2026-01-29 | Truist Securities | Maintains | Buy→Buy |
| 2026-01-08 | Truist Securities | Maintains | Buy→Buy |
| 2026-01-02 | Chardan Capital | Maintains | Buy→Buy |
| 2025-12-10 | Oppenheimer | Maintains | Outperform→Outperform |
| 2025-12-01 | B. Riley Securities | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Centessa Pharmaceuticals plc (CNTA) stock. Of the recent 42 rating actions, 3 were upgrades and 6 were downgrades. 14 analysts currently cover CNTA.
Analyst Recommendation Trends
CNTA analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$3M
↓ 98.3% YoY
Revenue Next Year
$25M
↑ 709.7% YoY
EPS This Year
$-1.69
EPS Next Year
$-1.81
↑ 7.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast CNTA EPS of $-1.69 for the current fiscal year, based on estimates from 2 analysts. The CNTA revenue forecast is $3M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The CNTA stock forecast is supported by two independent data sources: analyst consensus ratings from 14 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CNTA price target is $39.50 (-0.4% upside), with an analyst consensus of Buy.
The CNTA short-term stock prediction for tomorrow is $39.68 (+0.09%). The CNTA stock price prediction for 2027 estimates an average of $67. The CNTA stock prediction for 2030 projects a range of $134–$134.
Centessa Pharmaceuticals plc trades on NASDAQ under the ticker CNTA. The CNTA stock outlook for 2027 is broadly positive, supported by a Buy consensus among 57% of covering analysts.
Frequently asked questions
CNTA forecast · 8 questionsAccording to 14 Wall Street analysts, the average 12-month CNTA price target is $39.50, with a high forecast of $42.00 and a low of $38.00. The median price target is shown in the chart above when available. This implies -0.4% potential upside from the current price of $39.65.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.